{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:44:35Z","timestamp":1790772275286,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ando.2019.04.014","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T12:16:02Z","timestamp":1554984962000},"page":"187-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma"],"prefix":"10.1016","volume":"80","author":[{"given":"Rossella","family":"Elisei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bottici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Cappagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ramone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Tacito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ciampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2019.04.014_bib0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrendo.2012.38","article-title":"Advances in the follow-up of differentiated or medullary thyroid cancer","volume":"8","author":"Elisei","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2019.04.014_bib0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2019.04.014_bib0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2010.02.001","article-title":"Multiple endocrine neoplasia type 2","volume":"24","author":"Wohllk","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.04.014_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/705036","article-title":"Genetic and clinical features of multiple endocrine neoplasia types 1 and 2","volume":"2012","author":"Romei","year":"2012","journal-title":"J Oncol"},{"key":"10.1016\/j.ando.2019.04.014_bib0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/EJE-14-0817","article-title":"Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades","volume":"172","author":"Sarika","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2019.04.014_bib0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-10-0333","article-title":"Multiple endocrine neoplasia type 2 syndromes (MEN 2): Results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes","volume":"163","author":"Romei","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2019.04.014_bib0115","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jcem.86.8.7767","article-title":"Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients","volume":"86","author":"Niccoli-Sire","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.04.014_bib0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2007.12.016","article-title":"Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas","volume":"284","author":"Dvorakova","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2019.04.014_bib0125","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-11-0117","article-title":"In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer","volume":"18","author":"Cosci","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2019.04.014_bib0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2019.04.014_bib0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000346174","article-title":"2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer","volume":"1","author":"Elisei","year":"2013","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2019.04.014_bib0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2265.2010.03900.x","article-title":"RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)","volume":"74","author":"Romei","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2019.04.014_bib0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-014-1589-3","article-title":"High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas","volume":"465","author":"Simbolo","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ando.2019.04.014_bib0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1995.tb01903.x","article-title":"Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma","volume":"43","author":"Eng","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2019.04.014_bib0155","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1200\/JCO.2001.19.5.1374","article-title":"Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients","volume":"19","author":"Wiench","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2019.04.014_bib0160","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426619300666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426619300666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:52:28Z","timestamp":1757717548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426619300666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0003426619300666"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2019.04.014","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2019.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}